A volunteer has died in Brazil in a coronavirus ticker test invented by researchers at Oxford University in the United Kingdom. A statement from the Brazilian Ministry of Health said on Wednesday. However, officials at the University of Oxford and Brazil said the full trial would not be closed.
The marketing partner of this vaccine is AstraZeneca, a British pharmaceutical company. However, the organization declined to comment on any specific issues, citing confidentiality and clinical trials regulations.
Officials at the federal university of S. Paulo Paulo, who assisted in the trial, confirmed that the deceased volunteer was a Brazilian citizen.
The Brazilian Department of Health said that officials carefully reviewed the entire case. There are not many concerns about the safety of clinical trials.
According to local media in Brazil, the trial does not contain the vaccine; Instead, the volunteer was given a placebo.
Earlier last month, a volunteer in the third and final round in the UK fell ill and the trial was temporarily suspended. However, the identity of the person was not disclosed. However, such cases are not new in large clinical trials.
This Oxford vaccine candidate did very well in the first and second stage tests. But there is danger in the third and last phase. At this stage, about 30,000 people are being vaccinated in various countries. The vaccine will be released in the market based on its success.
This Oxford vaccine is considered the most advanced coronavirus vaccine worldwide. Meanwhile, four European countries have entered into an initial agreement with the company to pre-order 400 million doses of Corona ticker. Brazil also purchased the vaccine and plans to produce it at its biomedical research center.
In December 2019, coronavirus spread from Wuhan, the capital of Hubei Province, China. Although more than 63,000 people have been infected in the country of origin, China, the spread of the virus has decreased. However, the prevalence of the virus is increasing in other countries of the world. The World Health Organization (WHO) declared a global epidemic on March 11 in view of a 13-fold increase in the incidence of coronovirus outside China. Scientists are working hard to develop a vaccine against the virus.